235 related articles for article (PubMed ID: 21239703)
1. Prediction of the fetal status in noninvasive management of alloimmune thrombocytopenia.
Bertrand G; Drame M; Martageix C; Kaplan C
Blood; 2011 Mar; 117(11):3209-13. PubMed ID: 21239703
[TBL] [Abstract][Full Text] [Related]
2. Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage.
Delbos F; Bertrand G; Croisille L; Ansart-Pirenne H; Bierling P; Kaplan C
Transfusion; 2016 Jan; 56(1):59-66; quiz 58. PubMed ID: 26469867
[TBL] [Abstract][Full Text] [Related]
3. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
Kjeldsen-Kragh J; Bengtsson J
Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264
[TBL] [Abstract][Full Text] [Related]
4. New developments in fetal and neonatal alloimmune thrombocytopenia.
Bussel JB; Vander Haar EL; Berkowitz RL
Am J Obstet Gynecol; 2021 Aug; 225(2):120-127. PubMed ID: 33839095
[TBL] [Abstract][Full Text] [Related]
5. The implementation of surface plasmon resonance technique in monitoring pregnancies with expected fetal and neonatal alloimmune thrombocytopenia.
Bakchoul T; Bertrand G; Krautwurst A; Kroll H; Bein G; Sachs UJ; Santoso S; Kaplan C
Transfusion; 2013 Sep; 53(9):2078-85. PubMed ID: 23278334
[TBL] [Abstract][Full Text] [Related]
6. Neonatal alloimmune thrombocytopenia: antenatal management.
Silver RM; Porter TF; Branch DW; Esplin MS; Scott JR
Am J Obstet Gynecol; 2000 May; 182(5):1233-8. PubMed ID: 10819864
[TBL] [Abstract][Full Text] [Related]
7. A review of the contemporary management of fetal and neonatal alloimmune thrombocytopenia in an Australian tertiary obstetric hospital.
Cook TJ; Qiu CC; Dickinson JE
Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):321-6. PubMed ID: 22510050
[TBL] [Abstract][Full Text] [Related]
8. Antenatal intravenous immunoglobulins in pregnancies at risk of fetal and neonatal alloimmune thrombocytopenia: comparison of neonatal outcome in treated and nontreated pregnancies.
Ernstsen SL; Ahlen MT; Johansen T; Bertelsen EL; Kjeldsen-Kragh J; Tiller H
Am J Obstet Gynecol; 2022 Sep; 227(3):506.e1-506.e12. PubMed ID: 35500612
[TBL] [Abstract][Full Text] [Related]
9. Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopenia.
Lakkaraja M; Berkowitz RL; Vinograd CA; Manotas KC; Jin JC; Ferd P; Gabor J; Wissert M; McFarland JG; Bussel JB
Am J Obstet Gynecol; 2016 Oct; 215(4):471.e1-9. PubMed ID: 27131591
[TBL] [Abstract][Full Text] [Related]
10. Fetal and neonatal alloimmune thrombocytopenia.
van den Akker ES; Oepkes D
Best Pract Res Clin Obstet Gynaecol; 2008 Feb; 22(1):3-14. PubMed ID: 17936686
[TBL] [Abstract][Full Text] [Related]
11. Management and Neonatal Outcomes of Pregnancies with Fetal/Neonatal Alloimmune Thrombocytopenia: A Single-Center Retrospective Cohort Study.
Ronzoni S; Keunen J; Shah PS; Kelly EN; Windrim R; Seaward PG; Ryan G
Fetal Diagn Ther; 2019; 45(2):85-93. PubMed ID: 29669341
[TBL] [Abstract][Full Text] [Related]
12. Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT): Scientific Impact Paper No. 61.
Regan F; Lees CC; Jones B; Nicolaides KH; Wimalasundera RC; Mijovic A;
BJOG; 2019 Sep; 126(10):e173-e185. PubMed ID: 30968555
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive risk-assessment and bleeding prophylaxis with IVIG in pregnant women with a history of fetal and neonatal alloimmune thrombocytopenia: management to minimize adverse events.
Wienzek-Lischka S; Sawazki A; Ehrhardt H; Sachs UJ; Axt-Fliedner R; Bein G
Arch Gynecol Obstet; 2020 Aug; 302(2):355-363. PubMed ID: 32495019
[TBL] [Abstract][Full Text] [Related]
14. Fetomaternal alloimmune thrombocytopenia.
Ahya R; Turner ML; Urbaniak SJ;
Transfus Apher Sci; 2001 Oct; 25(2):139-45. PubMed ID: 11761276
[TBL] [Abstract][Full Text] [Related]
15. Antenatal management of fetomaternal alloimmune thrombocytopenia--report of 15 affected pregnancies.
Murphy MF; Waters AH; Doughty HA; Hambley H; Mibashan RS; Nicolaides K; Rodeck CH
Transfus Med; 1994 Dec; 4(4):281-92. PubMed ID: 7889140
[TBL] [Abstract][Full Text] [Related]
16. [Thirty years of platelet immunology in fetal and neonatal alloimmune thrombocytopenia management, current situation].
Petermann R
Transfus Clin Biol; 2017 Sep; 24(3):166-171. PubMed ID: 28673503
[TBL] [Abstract][Full Text] [Related]
17. Fetal/neonatal alloimmune thrombocytopenia due to anti-CD36 antibodies: antibody evaluations by CD36-transfected cell lines.
Lin M; Xu X; Lee HL; Liang DC; Santoso S
Transfusion; 2018 Jan; 58(1):189-195. PubMed ID: 29030871
[TBL] [Abstract][Full Text] [Related]
18. Long-term neurodevelopmental outcome in children after antenatal intravenous immune globulin treatment in fetal and neonatal alloimmune thrombocytopenia.
de Vos TW; de Haas M; Oepkes D; Tan RNGB; van der Schoot CE; Steggerda SJ; de Vries LS; Lopriore E; van Klink JMM
Am J Obstet Gynecol; 2022 Oct; 227(4):637.e1-637.e9. PubMed ID: 35671780
[TBL] [Abstract][Full Text] [Related]
19. Antiendothelial αvβ3 Antibodies Are a Major Cause of Intracranial Bleeding in Fetal/Neonatal Alloimmune Thrombocytopenia.
Santoso S; Wihadmadyatami H; Bakchoul T; Werth S; Al-Fakhri N; Bein G; Kiefel V; Zhu J; Newman PJ; Bayat B; Sachs UJ
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1517-24. PubMed ID: 27283740
[TBL] [Abstract][Full Text] [Related]
20. Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study.
de Vos TW; Winkelhorst D; Árnadóttir V; van der Bom JG; Canals Surís C; Caram-Deelder C; Deschmann E; Haysom HE; Hverven HBC; Lozar Krivec J; McQuilten ZK; Muñiz-Diaz E; Nogués N; Oepkes D; Porcelijn L; van der Schoot CE; Saxonhouse M; Sola-Visner M; Tiblad E; Tiller H; Wood EM; Young V; Železnik M; de Haas M; Lopriore E
Lancet Haematol; 2022 Nov; 9(11):e844-e853. PubMed ID: 36108655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
